HEADER TRANSFERASE 11-JUL-23 8PQC TITLE C-KIT KINASE DOMAIN IN COMPLEX WITH AVAPRITINIB DERIVATIVE 9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SCFR,PIEBALD TRAIT PROTEIN,PBT,PROTO-ONCOGENE C-KIT, COMPND 5 TYROSINE-PROTEIN KINASE KIT,P145 C-KIT,V-KIT HARDY-ZUCKERMAN 4 FELINE COMPND 6 SARCOMA VIRAL ONCOGENE HOMOLOG; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KIT, SCFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS C-KIT, PROTEIN KINASE, AVAPRITINIB, INHIBITOR, TYROSINE KINASE, KEYWDS 2 TRANSMEMBRANE RECEPTOR, STEM CELL FACTOR, STEM CELL FACTOR RECEPTOR, KEYWDS 3 GIST, GASTROINTESTINAL STROMAL TUMORS, P10721, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.TEUBER,S.B.KLEINBOELTING,M.P.MUELLER,D.RAUH REVDAT 3 13-MAR-24 8PQC 1 REMARK REVDAT 2 17-JAN-24 8PQC 1 JRNL REVDAT 1 27-DEC-23 8PQC 0 JRNL AUTH A.TEUBER,T.SCHULZ,B.S.FLETCHER,R.GONTLA,T.MUHLENBERG, JRNL AUTH 2 M.L.ZISCHINSKY,J.NIGGENABER,J.WEISNER,S.B.KLEINBOLTING, JRNL AUTH 3 J.LATEGAHN,S.SIEVERS,M.P.MULLER,S.BAUER,D.RAUH JRNL TITL AVAPRITINIB-BASED SAR STUDIES UNVEIL A BINDING POCKET IN KIT JRNL TITL 2 AND PDGFRA. JRNL REF NAT COMMUN V. 15 63 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 38167404 JRNL DOI 10.1038/S41467-023-44376-8 REMARK 2 REMARK 2 RESOLUTION. 1.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.53 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 67004 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3350 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.5300 - 5.1000 1.00 2888 153 0.1708 0.1963 REMARK 3 2 5.1000 - 4.0500 1.00 2741 144 0.1383 0.1451 REMARK 3 3 4.0500 - 3.5400 1.00 2700 142 0.1490 0.1625 REMARK 3 4 3.5400 - 3.2200 1.00 2692 142 0.1775 0.1896 REMARK 3 5 3.2200 - 2.9900 1.00 2665 140 0.1874 0.1989 REMARK 3 6 2.9900 - 2.8100 1.00 2661 140 0.1936 0.2244 REMARK 3 7 2.8100 - 2.6700 1.00 2687 141 0.1906 0.2154 REMARK 3 8 2.6700 - 2.5500 1.00 2639 139 0.1922 0.2221 REMARK 3 9 2.5500 - 2.4500 1.00 2623 138 0.1890 0.2602 REMARK 3 10 2.4500 - 2.3700 1.00 2628 139 0.1789 0.2118 REMARK 3 11 2.3700 - 2.3000 1.00 2666 140 0.1797 0.2202 REMARK 3 12 2.3000 - 2.2300 1.00 2658 140 0.1766 0.1984 REMARK 3 13 2.2300 - 2.1700 1.00 2613 138 0.1763 0.2282 REMARK 3 14 2.1700 - 2.1200 1.00 2613 137 0.1702 0.2039 REMARK 3 15 2.1200 - 2.0700 1.00 2639 139 0.2137 0.2414 REMARK 3 16 2.0700 - 2.0300 1.00 2640 138 0.2112 0.2641 REMARK 3 17 2.0300 - 1.9900 1.00 2602 137 0.2035 0.2197 REMARK 3 18 1.9900 - 1.9500 1.00 2592 137 0.2072 0.2238 REMARK 3 19 1.9500 - 1.9100 1.00 2630 138 0.2039 0.2669 REMARK 3 20 1.9100 - 1.8800 1.00 2669 140 0.2246 0.2758 REMARK 3 21 1.8800 - 1.8500 1.00 2533 134 0.2597 0.3583 REMARK 3 22 1.8500 - 1.8200 1.00 2678 141 0.2943 0.3515 REMARK 3 23 1.8200 - 1.8000 1.00 2563 135 0.3440 0.3121 REMARK 3 24 1.8000 - 1.7700 0.99 2634 138 0.3910 0.4003 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.241 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.018 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4946 REMARK 3 ANGLE : 0.944 6738 REMARK 3 CHIRALITY : 0.056 727 REMARK 3 PLANARITY : 0.008 857 REMARK 3 DIHEDRAL : 14.049 1781 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 566 THROUGH 630 ) REMARK 3 ORIGIN FOR THE GROUP (A): -14.1047 -3.3376 62.8627 REMARK 3 T TENSOR REMARK 3 T11: 0.2493 T22: 0.2094 REMARK 3 T33: 0.1852 T12: 0.0056 REMARK 3 T13: 0.0146 T23: 0.0140 REMARK 3 L TENSOR REMARK 3 L11: 2.1035 L22: 0.9708 REMARK 3 L33: 1.5949 L12: 0.7693 REMARK 3 L13: -0.3150 L23: 0.2859 REMARK 3 S TENSOR REMARK 3 S11: 0.0891 S12: -0.3415 S13: -0.0977 REMARK 3 S21: 0.2129 S22: -0.1332 S23: 0.0215 REMARK 3 S31: -0.1043 S32: -0.0881 S33: 0.0407 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 631 THROUGH 830 ) REMARK 3 ORIGIN FOR THE GROUP (A): -16.8670 -5.2354 47.6346 REMARK 3 T TENSOR REMARK 3 T11: 0.1865 T22: 0.1631 REMARK 3 T33: 0.1791 T12: 0.0277 REMARK 3 T13: 0.0029 T23: 0.0089 REMARK 3 L TENSOR REMARK 3 L11: 1.3030 L22: 1.3433 REMARK 3 L33: 3.7384 L12: 0.3714 REMARK 3 L13: 0.6049 L23: 0.4879 REMARK 3 S TENSOR REMARK 3 S11: 0.0042 S12: -0.1061 S13: -0.0178 REMARK 3 S21: -0.0424 S22: -0.0139 S23: 0.0062 REMARK 3 S31: -0.2233 S32: -0.2232 S33: 0.0105 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 831 THROUGH 932 ) REMARK 3 ORIGIN FOR THE GROUP (A): -12.9054 -12.0972 31.7757 REMARK 3 T TENSOR REMARK 3 T11: 0.1835 T22: 0.2227 REMARK 3 T33: 0.1501 T12: 0.0063 REMARK 3 T13: -0.0141 T23: -0.0131 REMARK 3 L TENSOR REMARK 3 L11: 3.1697 L22: 1.9788 REMARK 3 L33: 2.7600 L12: -0.5989 REMARK 3 L13: 0.6860 L23: 0.1094 REMARK 3 S TENSOR REMARK 3 S11: 0.0638 S12: 0.2245 S13: -0.1072 REMARK 3 S21: -0.1403 S22: -0.0302 S23: 0.0527 REMARK 3 S31: -0.1312 S32: 0.0739 S33: -0.0340 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'B' AND (RESID 567 THROUGH 688 ) REMARK 3 ORIGIN FOR THE GROUP (A): 7.1727 -0.1329 -12.0889 REMARK 3 T TENSOR REMARK 3 T11: 0.2041 T22: 0.2577 REMARK 3 T33: 0.2709 T12: 0.0292 REMARK 3 T13: -0.0218 T23: 0.0164 REMARK 3 L TENSOR REMARK 3 L11: 1.1455 L22: 1.6299 REMARK 3 L33: 1.6836 L12: 0.4313 REMARK 3 L13: 0.3656 L23: -0.3079 REMARK 3 S TENSOR REMARK 3 S11: -0.0993 S12: 0.0962 S13: 0.1236 REMARK 3 S21: -0.1185 S22: -0.0622 S23: -0.2224 REMARK 3 S31: -0.1344 S32: 0.0512 S33: 0.1461 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: CHAIN 'B' AND (RESID 689 THROUGH 786 ) REMARK 3 ORIGIN FOR THE GROUP (A): 3.6702 8.9344 8.3878 REMARK 3 T TENSOR REMARK 3 T11: 0.3238 T22: 0.3612 REMARK 3 T33: 0.3706 T12: 0.1212 REMARK 3 T13: -0.0923 T23: -0.0887 REMARK 3 L TENSOR REMARK 3 L11: 0.2106 L22: 3.2012 REMARK 3 L33: 0.7636 L12: -0.4308 REMARK 3 L13: -0.0961 L23: -1.0938 REMARK 3 S TENSOR REMARK 3 S11: -0.2189 S12: -0.2409 S13: 0.4562 REMARK 3 S21: 0.1183 S22: -0.0431 S23: 0.2956 REMARK 3 S31: -0.5234 S32: -0.4949 S33: 0.1490 REMARK 3 TLS GROUP : 6 REMARK 3 SELECTION: CHAIN 'B' AND (RESID 787 THROUGH 931 ) REMARK 3 ORIGIN FOR THE GROUP (A): 13.0879 -1.8449 10.7805 REMARK 3 T TENSOR REMARK 3 T11: 0.1753 T22: 0.1837 REMARK 3 T33: 0.1808 T12: 0.0250 REMARK 3 T13: -0.0222 T23: -0.0195 REMARK 3 L TENSOR REMARK 3 L11: 2.4702 L22: 1.2923 REMARK 3 L33: 2.7244 L12: -0.3616 REMARK 3 L13: 0.9372 L23: -0.1441 REMARK 3 S TENSOR REMARK 3 S11: -0.1033 S12: -0.2208 S13: 0.0876 REMARK 3 S21: 0.0617 S22: 0.0096 S23: 0.0315 REMARK 3 S31: -0.0511 S32: -0.3336 S33: 0.0752 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8PQC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1292131796. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-APR-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8731 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67020 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.770 REMARK 200 RESOLUTION RANGE LOW (A) : 48.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 11.60 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.0300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 6.72 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.480 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 6.6 MG/ML, 750 MM NA3-CITRATE, 100 MM REMARK 280 HEPES, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.61000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 96.30000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.61000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 96.30000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.61000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.61000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 548 REMARK 465 SER A 549 REMARK 465 MET A 550 REMARK 465 PRO A 551 REMARK 465 MET A 552 REMARK 465 TYR A 553 REMARK 465 GLU A 554 REMARK 465 VAL A 555 REMARK 465 GLN A 556 REMARK 465 TRP A 557 REMARK 465 LYS A 558 REMARK 465 VAL A 559 REMARK 465 VAL A 560 REMARK 465 GLU A 561 REMARK 465 GLU A 562 REMARK 465 SER A 563 REMARK 465 ASN A 564 REMARK 465 GLY A 565 REMARK 465 VAL A 754 REMARK 465 ALA A 755 REMARK 465 PRO A 756 REMARK 465 GLU A 757 REMARK 465 ASP A 758 REMARK 465 LEU A 759 REMARK 465 TYR A 760 REMARK 465 LYS A 761 REMARK 465 ASN A 819 REMARK 465 ASP A 820 REMARK 465 ASN A 933 REMARK 465 HIS A 934 REMARK 465 GLY B 548 REMARK 465 SER B 549 REMARK 465 MET B 550 REMARK 465 PRO B 551 REMARK 465 MET B 552 REMARK 465 TYR B 553 REMARK 465 GLU B 554 REMARK 465 VAL B 555 REMARK 465 GLN B 556 REMARK 465 TRP B 557 REMARK 465 LYS B 558 REMARK 465 VAL B 559 REMARK 465 VAL B 560 REMARK 465 GLU B 561 REMARK 465 GLU B 562 REMARK 465 SER B 563 REMARK 465 ASN B 564 REMARK 465 GLY B 565 REMARK 465 TYR B 752 REMARK 465 LYS B 753 REMARK 465 VAL B 754 REMARK 465 ALA B 755 REMARK 465 PRO B 756 REMARK 465 GLU B 757 REMARK 465 ASP B 758 REMARK 465 LEU B 759 REMARK 465 TYR B 760 REMARK 465 LYS B 761 REMARK 465 GLY B 827 REMARK 465 THR B 932 REMARK 465 ASN B 933 REMARK 465 HIS B 934 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 566 CG OD1 ND2 REMARK 470 LYS A 593 CG CD CE NZ REMARK 470 PHE A 600 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ILE A 612 CG1 CG2 CD1 REMARK 470 LYS A 613 CG CD CE NZ REMARK 470 SER A 614 OG REMARK 470 ASP A 615 CG OD1 OD2 REMARK 470 GLU A 688 CG CD OE1 OE2 REMARK 470 LYS A 693 CG CD CE NZ REMARK 470 ASP A 762 CG OD1 OD2 REMARK 470 PHE A 763 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 818 CG CD CE NZ REMARK 470 SER A 821 OG REMARK 470 LYS A 826 CG CD CE NZ REMARK 470 ASN A 828 CG OD1 ND2 REMARK 470 LYS A 926 CG CD CE NZ REMARK 470 SER A 931 OG REMARK 470 THR A 932 OG1 CG2 REMARK 470 ASN B 566 CG OD1 ND2 REMARK 470 LYS B 593 CG CD CE NZ REMARK 470 PHE B 600 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP B 762 CG OD1 OD2 REMARK 470 LYS B 818 CG CD CE NZ REMARK 470 SER B 821 OG REMARK 470 LYS B 826 CG CD CE NZ REMARK 470 ASN B 828 CG OD1 ND2 REMARK 470 LYS B 926 CG CD CE NZ REMARK 470 GLU B 930 CG CD OE1 OE2 REMARK 470 SER B 931 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 1226 O HOH B 1279 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1248 O HOH B 1240 3545 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 580 0.44 -69.69 REMARK 500 GLU A 688 59.98 -106.00 REMARK 500 ARG A 791 -0.37 73.11 REMARK 500 ASP A 792 47.85 -144.52 REMARK 500 ASP A 810 88.07 59.32 REMARK 500 ILE B 612 -57.42 69.94 REMARK 500 ARG B 791 -0.63 74.42 REMARK 500 ASP B 792 46.91 -144.10 REMARK 500 THR B 801 -168.19 -128.97 REMARK 500 ASP B 810 89.00 60.11 REMARK 500 SER B 821 -6.01 62.52 REMARK 500 REMARK 500 REMARK: NULL DBREF 8PQC A 551 687 UNP P10721 KIT_HUMAN 551 687 DBREF 8PQC A 766 934 UNP P10721 KIT_HUMAN 766 934 DBREF 8PQC B 551 687 UNP P10721 KIT_HUMAN 551 687 DBREF 8PQC B 766 934 UNP P10721 KIT_HUMAN 766 934 SEQADV 8PQC GLY A 548 UNP P10721 EXPRESSION TAG SEQADV 8PQC SER A 549 UNP P10721 EXPRESSION TAG SEQADV 8PQC MET A 550 UNP P10721 EXPRESSION TAG SEQADV 8PQC SER A 563 UNP P10721 ILE 563 ENGINEERED MUTATION SEQADV 8PQC SER A 569 UNP P10721 VAL 569 ENGINEERED MUTATION SEQADV 8PQC GLN A 609 UNP P10721 TYR 609 ENGINEERED MUTATION SEQADV 8PQC SER A 631 UNP P10721 LEU 631 ENGINEERED MUTATION SEQADV 8PQC GLU A 651 UNP P10721 MET 651 ENGINEERED MUTATION SEQADV 8PQC HIS A 662 UNP P10721 ILE 662 ENGINEERED MUTATION SEQADV 8PQC GLU A 688 UNP P10721 LINKER SEQADV 8PQC PHE A 689 UNP P10721 LINKER SEQADV 8PQC VAL A 690 UNP P10721 LINKER SEQADV 8PQC PRO A 691 UNP P10721 LINKER SEQADV 8PQC TYR A 692 UNP P10721 LINKER SEQADV 8PQC LYS A 693 UNP P10721 LINKER SEQADV 8PQC VAL A 754 UNP P10721 LINKER SEQADV 8PQC ALA A 755 UNP P10721 LINKER SEQADV 8PQC PRO A 756 UNP P10721 LINKER SEQADV 8PQC GLU A 757 UNP P10721 LINKER SEQADV 8PQC ASP A 758 UNP P10721 LINKER SEQADV 8PQC LEU A 759 UNP P10721 LINKER SEQADV 8PQC TYR A 760 UNP P10721 LINKER SEQADV 8PQC LYS A 761 UNP P10721 LINKER SEQADV 8PQC ASP A 762 UNP P10721 LINKER SEQADV 8PQC PHE A 763 UNP P10721 LINKER SEQADV 8PQC LEU A 764 UNP P10721 LINKER SEQADV 8PQC THR A 765 UNP P10721 LINKER SEQADV 8PQC HIS A 768 UNP P10721 ASP 768 ENGINEERED MUTATION SEQADV 8PQC ASN A 804 UNP P10721 ARG 804 ENGINEERED MUTATION SEQADV 8PQC ASP A 825 UNP P10721 VAL 825 ENGINEERED MUTATION SEQADV 8PQC SER A 844 UNP P10721 CYS 844 ENGINEERED MUTATION SEQADV 8PQC SER A 890 UNP P10721 LEU 890 ENGINEERED MUTATION SEQADV 8PQC TYR A 894 UNP P10721 HIS 894 ENGINEERED MUTATION SEQADV 8PQC ASP A 912 UNP P10721 LEU 912 ENGINEERED MUTATION SEQADV 8PQC ASP A 923 UNP P10721 LEU 923 ENGINEERED MUTATION SEQADV 8PQC GLY B 548 UNP P10721 EXPRESSION TAG SEQADV 8PQC SER B 549 UNP P10721 EXPRESSION TAG SEQADV 8PQC MET B 550 UNP P10721 EXPRESSION TAG SEQADV 8PQC SER B 563 UNP P10721 ILE 563 ENGINEERED MUTATION SEQADV 8PQC SER B 569 UNP P10721 VAL 569 ENGINEERED MUTATION SEQADV 8PQC GLN B 609 UNP P10721 TYR 609 ENGINEERED MUTATION SEQADV 8PQC SER B 631 UNP P10721 LEU 631 ENGINEERED MUTATION SEQADV 8PQC GLU B 651 UNP P10721 MET 651 ENGINEERED MUTATION SEQADV 8PQC HIS B 662 UNP P10721 ILE 662 ENGINEERED MUTATION SEQADV 8PQC GLU B 688 UNP P10721 LINKER SEQADV 8PQC PHE B 689 UNP P10721 LINKER SEQADV 8PQC VAL B 690 UNP P10721 LINKER SEQADV 8PQC PRO B 691 UNP P10721 LINKER SEQADV 8PQC TYR B 752 UNP P10721 LINKER SEQADV 8PQC LYS B 753 UNP P10721 LINKER SEQADV 8PQC VAL B 754 UNP P10721 LINKER SEQADV 8PQC ALA B 755 UNP P10721 LINKER SEQADV 8PQC PRO B 756 UNP P10721 LINKER SEQADV 8PQC GLU B 757 UNP P10721 LINKER SEQADV 8PQC ASP B 758 UNP P10721 LINKER SEQADV 8PQC LEU B 759 UNP P10721 LINKER SEQADV 8PQC TYR B 760 UNP P10721 LINKER SEQADV 8PQC LYS B 761 UNP P10721 LINKER SEQADV 8PQC ASP B 762 UNP P10721 LINKER SEQADV 8PQC PHE B 763 UNP P10721 LINKER SEQADV 8PQC LEU B 764 UNP P10721 LINKER SEQADV 8PQC THR B 765 UNP P10721 LINKER SEQADV 8PQC HIS B 768 UNP P10721 ASP 768 ENGINEERED MUTATION SEQADV 8PQC ASN B 804 UNP P10721 ARG 804 ENGINEERED MUTATION SEQADV 8PQC ASP B 825 UNP P10721 VAL 825 ENGINEERED MUTATION SEQADV 8PQC SER B 844 UNP P10721 CYS 844 ENGINEERED MUTATION SEQADV 8PQC SER B 890 UNP P10721 LEU 890 ENGINEERED MUTATION SEQADV 8PQC TYR B 894 UNP P10721 HIS 894 ENGINEERED MUTATION SEQADV 8PQC ASP B 912 UNP P10721 LEU 912 ENGINEERED MUTATION SEQADV 8PQC ASP B 923 UNP P10721 LEU 923 ENGINEERED MUTATION SEQRES 1 A 327 GLY SER MET PRO MET TYR GLU VAL GLN TRP LYS VAL VAL SEQRES 2 A 327 GLU GLU SER ASN GLY ASN ASN TYR SER TYR ILE ASP PRO SEQRES 3 A 327 THR GLN LEU PRO TYR ASP HIS LYS TRP GLU PHE PRO ARG SEQRES 4 A 327 ASN ARG LEU SER PHE GLY LYS THR LEU GLY ALA GLY ALA SEQRES 5 A 327 PHE GLY LYS VAL VAL GLU ALA THR ALA GLN GLY LEU ILE SEQRES 6 A 327 LYS SER ASP ALA ALA MET THR VAL ALA VAL LYS MET LEU SEQRES 7 A 327 LYS PRO SER ALA HIS SER THR GLU ARG GLU ALA LEU MET SEQRES 8 A 327 SER GLU LEU LYS VAL LEU SER TYR LEU GLY ASN HIS GLU SEQRES 9 A 327 ASN ILE VAL ASN LEU LEU GLY ALA CYS THR HIS GLY GLY SEQRES 10 A 327 PRO THR LEU VAL ILE THR GLU TYR CYS CYS TYR GLY ASP SEQRES 11 A 327 LEU LEU ASN PHE LEU ARG ARG LYS ARG ASP GLU PHE VAL SEQRES 12 A 327 PRO TYR LYS VAL ALA PRO GLU ASP LEU TYR LYS ASP PHE SEQRES 13 A 327 LEU THR LEU GLU HIS LEU LEU SER PHE SER TYR GLN VAL SEQRES 14 A 327 ALA LYS GLY MET ALA PHE LEU ALA SER LYS ASN CYS ILE SEQRES 15 A 327 HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU LEU THR HIS SEQRES 16 A 327 GLY ASN ILE THR LYS ILE CYS ASP PHE GLY LEU ALA ARG SEQRES 17 A 327 ASP ILE LYS ASN ASP SER ASN TYR VAL ASP LYS GLY ASN SEQRES 18 A 327 ALA ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SER ILE SEQRES 19 A 327 PHE ASN SER VAL TYR THR PHE GLU SER ASP VAL TRP SER SEQRES 20 A 327 TYR GLY ILE PHE LEU TRP GLU LEU PHE SER LEU GLY SER SEQRES 21 A 327 SER PRO TYR PRO GLY MET PRO VAL ASP SER LYS PHE TYR SEQRES 22 A 327 LYS MET ILE LYS GLU GLY PHE ARG MET SER SER PRO GLU SEQRES 23 A 327 TYR ALA PRO ALA GLU MET TYR ASP ILE MET LYS THR CYS SEQRES 24 A 327 TRP ASP ALA ASP PRO ASP LYS ARG PRO THR PHE LYS GLN SEQRES 25 A 327 ILE VAL GLN ASP ILE GLU LYS GLN ILE SER GLU SER THR SEQRES 26 A 327 ASN HIS SEQRES 1 B 327 GLY SER MET PRO MET TYR GLU VAL GLN TRP LYS VAL VAL SEQRES 2 B 327 GLU GLU SER ASN GLY ASN ASN TYR SER TYR ILE ASP PRO SEQRES 3 B 327 THR GLN LEU PRO TYR ASP HIS LYS TRP GLU PHE PRO ARG SEQRES 4 B 327 ASN ARG LEU SER PHE GLY LYS THR LEU GLY ALA GLY ALA SEQRES 5 B 327 PHE GLY LYS VAL VAL GLU ALA THR ALA GLN GLY LEU ILE SEQRES 6 B 327 LYS SER ASP ALA ALA MET THR VAL ALA VAL LYS MET LEU SEQRES 7 B 327 LYS PRO SER ALA HIS SER THR GLU ARG GLU ALA LEU MET SEQRES 8 B 327 SER GLU LEU LYS VAL LEU SER TYR LEU GLY ASN HIS GLU SEQRES 9 B 327 ASN ILE VAL ASN LEU LEU GLY ALA CYS THR HIS GLY GLY SEQRES 10 B 327 PRO THR LEU VAL ILE THR GLU TYR CYS CYS TYR GLY ASP SEQRES 11 B 327 LEU LEU ASN PHE LEU ARG ARG LYS ARG ASP GLU PHE VAL SEQRES 12 B 327 PRO TYR LYS VAL ALA PRO GLU ASP LEU TYR LYS ASP PHE SEQRES 13 B 327 LEU THR LEU GLU HIS LEU LEU SER PHE SER TYR GLN VAL SEQRES 14 B 327 ALA LYS GLY MET ALA PHE LEU ALA SER LYS ASN CYS ILE SEQRES 15 B 327 HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU LEU THR HIS SEQRES 16 B 327 GLY ASN ILE THR LYS ILE CYS ASP PHE GLY LEU ALA ARG SEQRES 17 B 327 ASP ILE LYS ASN ASP SER ASN TYR VAL ASP LYS GLY ASN SEQRES 18 B 327 ALA ARG LEU PRO VAL LYS TRP MET ALA PRO GLU SER ILE SEQRES 19 B 327 PHE ASN SER VAL TYR THR PHE GLU SER ASP VAL TRP SER SEQRES 20 B 327 TYR GLY ILE PHE LEU TRP GLU LEU PHE SER LEU GLY SER SEQRES 21 B 327 SER PRO TYR PRO GLY MET PRO VAL ASP SER LYS PHE TYR SEQRES 22 B 327 LYS MET ILE LYS GLU GLY PHE ARG MET SER SER PRO GLU SEQRES 23 B 327 TYR ALA PRO ALA GLU MET TYR ASP ILE MET LYS THR CYS SEQRES 24 B 327 TRP ASP ALA ASP PRO ASP LYS ARG PRO THR PHE LYS GLN SEQRES 25 B 327 ILE VAL GLN ASP ILE GLU LYS GLN ILE SER GLU SER THR SEQRES 26 B 327 ASN HIS HET 9OO A1001 39 HET 9OO B1001 39 HETNAM 9OO (1~{S})-~{N}-ETHYL-1-(4-FLUOROPHENYL)-1-[2-[4-[6-(1- HETNAM 2 9OO METHYLPYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4- HETNAM 3 9OO YL]PIPERAZIN-1-YL]PYRIMIDIN-5-YL]ETHANAMINE FORMUL 3 9OO 2(C28 H31 F N10) FORMUL 5 HOH *371(H2 O) HELIX 1 AA1 ASP A 572 LEU A 576 5 5 HELIX 2 AA2 ASP A 579 GLU A 583 5 5 HELIX 3 AA3 PRO A 585 ASN A 587 5 3 HELIX 4 AA4 HIS A 630 GLY A 648 1 19 HELIX 5 AA5 LEU A 678 ARG A 686 1 9 HELIX 6 AA6 THR A 765 LYS A 786 1 22 HELIX 7 AA7 ALA A 794 ARG A 796 5 3 HELIX 8 AA8 HIS A 802 ASN A 804 5 3 HELIX 9 AA9 PRO A 832 MET A 836 5 5 HELIX 10 AB1 ALA A 837 SER A 844 1 8 HELIX 11 AB2 THR A 847 SER A 864 1 18 HELIX 12 AB3 ASP A 876 GLY A 886 1 11 HELIX 13 AB4 PRO A 896 TRP A 907 1 12 HELIX 14 AB5 ASP A 910 ARG A 914 5 5 HELIX 15 AB6 THR A 916 THR A 932 1 17 HELIX 16 AB7 ASP B 572 LEU B 576 5 5 HELIX 17 AB8 ASP B 579 GLU B 583 5 5 HELIX 18 AB9 PRO B 585 ASN B 587 5 3 HELIX 19 AC1 HIS B 630 GLY B 648 1 19 HELIX 20 AC2 LEU B 678 ARG B 686 1 9 HELIX 21 AC3 ASP B 687 PHE B 689 5 3 HELIX 22 AC4 THR B 765 LYS B 786 1 22 HELIX 23 AC5 ALA B 794 ARG B 796 5 3 HELIX 24 AC6 HIS B 802 ASN B 804 5 3 HELIX 25 AC7 PRO B 832 MET B 836 5 5 HELIX 26 AC8 ALA B 837 SER B 844 1 8 HELIX 27 AC9 THR B 847 SER B 864 1 18 HELIX 28 AD1 ASP B 876 GLY B 886 1 11 HELIX 29 AD2 PRO B 896 TRP B 907 1 12 HELIX 30 AD3 ASP B 910 ARG B 914 5 5 HELIX 31 AD4 THR B 916 SER B 931 1 16 SHEET 1 AA1 5 LEU A 589 ALA A 597 0 SHEET 2 AA1 5 GLY A 601 GLN A 609 -1 O GLU A 605 N GLY A 592 SHEET 3 AA1 5 ALA A 617 LEU A 625 -1 O VAL A 620 N ALA A 606 SHEET 4 AA1 5 LEU A 667 GLU A 671 -1 O THR A 670 N ALA A 621 SHEET 5 AA1 5 LEU A 656 CYS A 660 -1 N LEU A 657 O ILE A 669 SHEET 1 AA2 3 GLY A 676 ASP A 677 0 SHEET 2 AA2 3 ILE A 798 THR A 801 -1 O LEU A 800 N GLY A 676 SHEET 3 AA2 3 ILE A 805 ILE A 808 -1 O LYS A 807 N LEU A 799 SHEET 1 AA3 2 CYS A 788 ILE A 789 0 SHEET 2 AA3 2 ARG A 815 ASP A 816 -1 O ARG A 815 N ILE A 789 SHEET 1 AA4 2 TYR A 823 VAL A 824 0 SHEET 2 AA4 2 VAL A 845 TYR A 846 -1 O TYR A 846 N TYR A 823 SHEET 1 AA5 5 LEU B 589 ALA B 597 0 SHEET 2 AA5 5 GLY B 601 GLN B 609 -1 O GLU B 605 N GLY B 592 SHEET 3 AA5 5 ALA B 617 LEU B 625 -1 O MET B 618 N ALA B 608 SHEET 4 AA5 5 LEU B 667 GLU B 671 -1 O VAL B 668 N LYS B 623 SHEET 5 AA5 5 LEU B 656 CYS B 660 -1 N LEU B 657 O ILE B 669 SHEET 1 AA6 3 GLY B 676 ASP B 677 0 SHEET 2 AA6 3 ILE B 798 THR B 801 -1 O LEU B 800 N GLY B 676 SHEET 3 AA6 3 ILE B 805 ILE B 808 -1 O LYS B 807 N LEU B 799 SHEET 1 AA7 2 CYS B 788 ILE B 789 0 SHEET 2 AA7 2 ARG B 815 ASP B 816 -1 O ARG B 815 N ILE B 789 SHEET 1 AA8 2 TYR B 823 VAL B 824 0 SHEET 2 AA8 2 VAL B 845 TYR B 846 -1 O TYR B 846 N TYR B 823 CISPEP 1 GLY B 664 PRO B 665 0 -0.80 CRYST1 59.220 59.220 192.600 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016886 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016886 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005192 0.00000